nodes	percent_of_prediction	percent_of_DWPC	metapath
Eprosartan—ABCC2—Indinavir—acquired immunodeficiency syndrome	0.101	0.142	CbGbCtD
Eprosartan—ABCC2—Ritonavir—acquired immunodeficiency syndrome	0.0891	0.125	CbGbCtD
Eprosartan—ABCC2—Saquinavir—acquired immunodeficiency syndrome	0.0891	0.125	CbGbCtD
Eprosartan—ABCC2—Lamivudine—acquired immunodeficiency syndrome	0.0661	0.0925	CbGbCtD
Eprosartan—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0464	0.065	CbGbCtD
Eprosartan—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0437	0.0611	CbGbCtD
Eprosartan—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0437	0.0611	CbGbCtD
Eprosartan—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0395	0.0553	CbGbCtD
Eprosartan—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0395	0.0553	CbGbCtD
Eprosartan—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0341	0.0477	CbGbCtD
Eprosartan—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0331	0.0463	CbGbCtD
Eprosartan—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0299	0.0419	CbGbCtD
Eprosartan—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0299	0.0419	CbGbCtD
Eprosartan—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.0287	0.0402	CbGbCtD
Eprosartan—AGTR1—endothelium—acquired immunodeficiency syndrome	0.00315	0.184	CbGeAlD
Eprosartan—AGTR1—blood plasma—acquired immunodeficiency syndrome	0.0028	0.163	CbGeAlD
Eprosartan—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00135	0.0787	CbGeAlD
Eprosartan—AGTR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00109	0.0636	CbGeAlD
Eprosartan—AGTR1—blood—acquired immunodeficiency syndrome	0.00103	0.0599	CbGeAlD
Eprosartan—AGTR1—vagina—acquired immunodeficiency syndrome	0.000951	0.0555	CbGeAlD
Eprosartan—AGTR1—lung—acquired immunodeficiency syndrome	0.000899	0.0525	CbGeAlD
Eprosartan—AGTR1—nervous system—acquired immunodeficiency syndrome	0.000833	0.0486	CbGeAlD
Eprosartan—AGTR1—central nervous system—acquired immunodeficiency syndrome	0.000802	0.0468	CbGeAlD
Eprosartan—ABCC2—digestive system—acquired immunodeficiency syndrome	0.000778	0.0454	CbGeAlD
Eprosartan—ABCC2—blood—acquired immunodeficiency syndrome	0.000741	0.0433	CbGeAlD
Eprosartan—AGTR1—brain—acquired immunodeficiency syndrome	0.000636	0.0372	CbGeAlD
Eprosartan—AGTR1—lymph node—acquired immunodeficiency syndrome	0.000615	0.0359	CbGeAlD
Eprosartan—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000518	0.0303	CbGeAlD
Eprosartan—CYP2C9—blood—acquired immunodeficiency syndrome	0.000494	0.0288	CbGeAlD
Eprosartan—AGTR1—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.000476	0.0686	CbGpPWpGaD
Eprosartan—ABCC2—lymph node—acquired immunodeficiency syndrome	0.000445	0.026	CbGeAlD
Eprosartan—Losartan—ALB—acquired immunodeficiency syndrome	0.000417	1	CrCbGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL3L1—acquired immunodeficiency syndrome	0.000369	0.0533	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.000266	0.0383	CbGpPWpGaD
Eprosartan—AGTR1—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.00025	0.036	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000248	0.0357	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	0.000237	0.0342	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—ACKR1—acquired immunodeficiency syndrome	0.000224	0.0323	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL4—acquired immunodeficiency syndrome	0.000202	0.0292	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000189	0.0272	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	0.00018	0.0259	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	0.00018	0.0259	CbGpPWpGaD
Eprosartan—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000177	0.000678	CcSEcCtD
Eprosartan—Headache—Didanosine—acquired immunodeficiency syndrome	0.000177	0.000677	CcSEcCtD
Eprosartan—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000177	0.000676	CcSEcCtD
Eprosartan—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000176	0.000675	CcSEcCtD
Eprosartan—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000176	0.000674	CcSEcCtD
Eprosartan—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000674	CcSEcCtD
Eprosartan—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000176	0.000674	CcSEcCtD
Eprosartan—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000176	0.000673	CcSEcCtD
Eprosartan—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000176	0.000672	CcSEcCtD
Eprosartan—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000176	0.000672	CcSEcCtD
Eprosartan—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000671	CcSEcCtD
Eprosartan—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.00067	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	0.000175	0.0252	CbGpPWpGaD
Eprosartan—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000175	0.000669	CcSEcCtD
Eprosartan—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000175	0.000668	CcSEcCtD
Eprosartan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000174	0.000667	CcSEcCtD
Eprosartan—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000174	0.000667	CcSEcCtD
Eprosartan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000174	0.000666	CcSEcCtD
Eprosartan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000174	0.000665	CcSEcCtD
Eprosartan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000173	0.000664	CcSEcCtD
Eprosartan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000173	0.000663	CcSEcCtD
Eprosartan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.000663	CcSEcCtD
Eprosartan—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000662	CcSEcCtD
Eprosartan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000661	CcSEcCtD
Eprosartan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000661	CcSEcCtD
Eprosartan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.000661	CcSEcCtD
Eprosartan—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000659	CcSEcCtD
Eprosartan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.000659	CcSEcCtD
Eprosartan—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000172	0.000657	CcSEcCtD
Eprosartan—AGTR1—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.000171	0.0247	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	0.000171	0.0247	CbGpPWpGaD
Eprosartan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000171	0.000654	CcSEcCtD
Eprosartan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000654	CcSEcCtD
Eprosartan—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000653	CcSEcCtD
Eprosartan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000653	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.000653	CcSEcCtD
Eprosartan—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00017	0.000652	CcSEcCtD
Eprosartan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000652	CcSEcCtD
Eprosartan—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000648	CcSEcCtD
Eprosartan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000169	0.000648	CcSEcCtD
Eprosartan—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000648	CcSEcCtD
Eprosartan—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000169	0.000648	CcSEcCtD
Eprosartan—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000647	CcSEcCtD
Eprosartan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000644	CcSEcCtD
Eprosartan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.000644	CcSEcCtD
Eprosartan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000168	0.000644	CcSEcCtD
Eprosartan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.000643	CcSEcCtD
Eprosartan—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000168	0.000643	CcSEcCtD
Eprosartan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000168	0.000642	CcSEcCtD
Eprosartan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000168	0.000642	CcSEcCtD
Eprosartan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000641	CcSEcCtD
Eprosartan—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00064	CcSEcCtD
Eprosartan—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00064	CcSEcCtD
Eprosartan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000167	0.000639	CcSEcCtD
Eprosartan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000166	0.000637	CcSEcCtD
Eprosartan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000636	CcSEcCtD
Eprosartan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000636	CcSEcCtD
Eprosartan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000636	CcSEcCtD
Eprosartan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.000634	CcSEcCtD
Eprosartan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000165	0.000632	CcSEcCtD
Eprosartan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000165	0.000631	CcSEcCtD
Eprosartan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000164	0.000629	CcSEcCtD
Eprosartan—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000627	CcSEcCtD
Eprosartan—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000163	0.000625	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000624	CcSEcCtD
Eprosartan—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000163	0.000624	CcSEcCtD
Eprosartan—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.000623	CcSEcCtD
Eprosartan—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000622	CcSEcCtD
Eprosartan—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000163	0.000622	CcSEcCtD
Eprosartan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000163	0.000622	CcSEcCtD
Eprosartan—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000621	CcSEcCtD
Eprosartan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000162	0.00062	CcSEcCtD
Eprosartan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000162	0.00062	CcSEcCtD
Eprosartan—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000162	0.00062	CcSEcCtD
Eprosartan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000162	0.000619	CcSEcCtD
Eprosartan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000161	0.000618	CcSEcCtD
Eprosartan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000618	CcSEcCtD
Eprosartan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000615	CcSEcCtD
Eprosartan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.000613	CcSEcCtD
Eprosartan—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000613	CcSEcCtD
Eprosartan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00016	0.000613	CcSEcCtD
Eprosartan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.00016	0.000613	CcSEcCtD
Eprosartan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.00016	0.000612	CcSEcCtD
Eprosartan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.00016	0.000611	CcSEcCtD
Eprosartan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.00016	0.000611	CcSEcCtD
Eprosartan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000159	0.000609	CcSEcCtD
Eprosartan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.000609	CcSEcCtD
Eprosartan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000607	CcSEcCtD
Eprosartan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000607	CcSEcCtD
Eprosartan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.000607	CcSEcCtD
Eprosartan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000605	CcSEcCtD
Eprosartan—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000604	CcSEcCtD
Eprosartan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000158	0.000603	CcSEcCtD
Eprosartan—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000602	CcSEcCtD
Eprosartan—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000157	0.0006	CcSEcCtD
Eprosartan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.0006	CcSEcCtD
Eprosartan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000599	CcSEcCtD
Eprosartan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000157	0.000599	CcSEcCtD
Eprosartan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000156	0.000598	CcSEcCtD
Eprosartan—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000156	0.000597	CcSEcCtD
Eprosartan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000156	0.000596	CcSEcCtD
Eprosartan—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000596	CcSEcCtD
Eprosartan—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000594	CcSEcCtD
Eprosartan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.000593	CcSEcCtD
Eprosartan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.000593	CcSEcCtD
Eprosartan—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000592	CcSEcCtD
Eprosartan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000155	0.000591	CcSEcCtD
Eprosartan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000591	CcSEcCtD
Eprosartan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000154	0.000591	CcSEcCtD
Eprosartan—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000154	0.00059	CcSEcCtD
Eprosartan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00059	CcSEcCtD
Eprosartan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.000589	CcSEcCtD
Eprosartan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000154	0.000588	CcSEcCtD
Eprosartan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000154	0.000588	CcSEcCtD
Eprosartan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000586	CcSEcCtD
Eprosartan—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000153	0.000586	CcSEcCtD
Eprosartan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000153	0.000586	CcSEcCtD
Eprosartan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000153	0.000585	CcSEcCtD
Eprosartan—Rash—Abacavir—acquired immunodeficiency syndrome	0.000152	0.000583	CcSEcCtD
Eprosartan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000152	0.000582	CcSEcCtD
Eprosartan—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000582	CcSEcCtD
Eprosartan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000151	0.000579	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000577	CcSEcCtD
Eprosartan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000151	0.000577	CcSEcCtD
Eprosartan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000151	0.000577	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00015	0.0216	CbGpPWpGaD
Eprosartan—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000573	CcSEcCtD
Eprosartan—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.000573	CcSEcCtD
Eprosartan—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00057	CcSEcCtD
Eprosartan—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000149	0.00057	CcSEcCtD
Eprosartan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000569	CcSEcCtD
Eprosartan—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000149	0.000569	CcSEcCtD
Eprosartan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000566	CcSEcCtD
Eprosartan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.000566	CcSEcCtD
Eprosartan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000148	0.000565	CcSEcCtD
Eprosartan—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000148	0.000565	CcSEcCtD
Eprosartan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000147	0.000563	CcSEcCtD
Eprosartan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.000563	CcSEcCtD
Eprosartan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000146	0.00056	CcSEcCtD
Eprosartan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000146	0.000559	CcSEcCtD
Eprosartan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000146	0.000559	CcSEcCtD
Eprosartan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000146	0.000558	CcSEcCtD
Eprosartan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000146	0.000558	CcSEcCtD
Eprosartan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000146	0.000557	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000556	CcSEcCtD
Eprosartan—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000555	CcSEcCtD
Eprosartan—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000552	CcSEcCtD
Eprosartan—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000551	CcSEcCtD
Eprosartan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000143	0.000549	CcSEcCtD
Eprosartan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.000548	CcSEcCtD
Eprosartan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000546	CcSEcCtD
Eprosartan—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000545	CcSEcCtD
Eprosartan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000142	0.000544	CcSEcCtD
Eprosartan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000544	CcSEcCtD
Eprosartan—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000544	CcSEcCtD
Eprosartan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000142	0.000542	CcSEcCtD
Eprosartan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000542	CcSEcCtD
Eprosartan—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000542	CcSEcCtD
Eprosartan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000542	CcSEcCtD
Eprosartan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000542	CcSEcCtD
Eprosartan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000539	CcSEcCtD
Eprosartan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000537	CcSEcCtD
Eprosartan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000536	CcSEcCtD
Eprosartan—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.00053	CcSEcCtD
Eprosartan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00053	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL3—acquired immunodeficiency syndrome	0.000138	0.0199	CbGpPWpGaD
Eprosartan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000138	0.000528	CcSEcCtD
Eprosartan—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000526	CcSEcCtD
Eprosartan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000526	CcSEcCtD
Eprosartan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000523	CcSEcCtD
Eprosartan—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000522	CcSEcCtD
Eprosartan—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000522	CcSEcCtD
Eprosartan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000522	CcSEcCtD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000136	0.0196	CbGpPWpGaD
Eprosartan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000136	0.000519	CcSEcCtD
Eprosartan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000136	0.000519	CcSEcCtD
Eprosartan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.000518	CcSEcCtD
Eprosartan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000135	0.000518	CcSEcCtD
Eprosartan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000135	0.000517	CcSEcCtD
Eprosartan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000514	CcSEcCtD
Eprosartan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000514	CcSEcCtD
Eprosartan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000134	0.000514	CcSEcCtD
Eprosartan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000512	CcSEcCtD
Eprosartan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000511	CcSEcCtD
Eprosartan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.000507	CcSEcCtD
Eprosartan—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000506	CcSEcCtD
Eprosartan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000132	0.000505	CcSEcCtD
Eprosartan—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000504	CcSEcCtD
Eprosartan—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000503	CcSEcCtD
Eprosartan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.000502	CcSEcCtD
Eprosartan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000501	CcSEcCtD
Eprosartan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000501	CcSEcCtD
Eprosartan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.000501	CcSEcCtD
Eprosartan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00013	0.000499	CcSEcCtD
Eprosartan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000498	CcSEcCtD
Eprosartan—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000498	CcSEcCtD
Eprosartan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000492	CcSEcCtD
Eprosartan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000128	0.00049	CcSEcCtD
Eprosartan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000485	CcSEcCtD
Eprosartan—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000485	CcSEcCtD
Eprosartan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000127	0.000484	CcSEcCtD
Eprosartan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000482	CcSEcCtD
Eprosartan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.000482	CcSEcCtD
Eprosartan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000126	0.000482	CcSEcCtD
Eprosartan—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.00048	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR2—acquired immunodeficiency syndrome	0.000125	0.018	CbGpPWpGaD
Eprosartan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000478	CcSEcCtD
Eprosartan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000125	0.000478	CcSEcCtD
Eprosartan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000124	0.000476	CcSEcCtD
Eprosartan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000475	CcSEcCtD
Eprosartan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000474	CcSEcCtD
Eprosartan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000123	0.000469	CcSEcCtD
Eprosartan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000122	0.000467	CcSEcCtD
Eprosartan—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000462	CcSEcCtD
Eprosartan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00046	CcSEcCtD
Eprosartan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00046	CcSEcCtD
Eprosartan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000119	0.000455	CcSEcCtD
Eprosartan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000455	CcSEcCtD
Eprosartan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000453	CcSEcCtD
Eprosartan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000452	CcSEcCtD
Eprosartan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.000451	CcSEcCtD
Eprosartan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000118	0.00045	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCL12—acquired immunodeficiency syndrome	0.000118	0.017	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CXCR4—acquired immunodeficiency syndrome	0.000118	0.017	CbGpPWpGaD
Eprosartan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000449	CcSEcCtD
Eprosartan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000449	CcSEcCtD
Eprosartan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000448	CcSEcCtD
Eprosartan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000438	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000114	0.0165	CbGpPWpGaD
Eprosartan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000114	0.000436	CcSEcCtD
Eprosartan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000113	0.000434	CcSEcCtD
Eprosartan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000432	CcSEcCtD
Eprosartan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.000432	CcSEcCtD
Eprosartan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000432	CcSEcCtD
Eprosartan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000429	CcSEcCtD
Eprosartan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000112	0.000429	CcSEcCtD
Eprosartan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000111	0.000426	CcSEcCtD
Eprosartan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000419	CcSEcCtD
Eprosartan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000418	CcSEcCtD
Eprosartan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000109	0.000417	CcSEcCtD
Eprosartan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000412	CcSEcCtD
Eprosartan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000407	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	0.000106	0.0152	CbGpPWpGaD
Eprosartan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000403	CcSEcCtD
Eprosartan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.000403	CcSEcCtD
Eprosartan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.0004	CcSEcCtD
Eprosartan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000399	CcSEcCtD
Eprosartan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000104	0.000398	CcSEcCtD
Eprosartan—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000397	CcSEcCtD
Eprosartan—AGTR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000103	0.0149	CbGpPWpGaD
Eprosartan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000388	CcSEcCtD
Eprosartan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000385	CcSEcCtD
Eprosartan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.000385	CcSEcCtD
Eprosartan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.0001	0.000384	CcSEcCtD
Eprosartan—Headache—Saquinavir—acquired immunodeficiency syndrome	9.99e-05	0.000382	CcSEcCtD
Eprosartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—acquired immunodeficiency syndrome	9.87e-05	0.0142	CbGpPWpGaD
Eprosartan—Nausea—Ritonavir—acquired immunodeficiency syndrome	9.84e-05	0.000376	CcSEcCtD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	9.79e-05	0.0141	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.68e-05	0.014	CbGpPWpGaD
Eprosartan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	9.67e-05	0.00037	CcSEcCtD
Eprosartan—Rash—Lamivudine—acquired immunodeficiency syndrome	9.59e-05	0.000367	CcSEcCtD
Eprosartan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	9.58e-05	0.000367	CcSEcCtD
Eprosartan—Headache—Lamivudine—acquired immunodeficiency syndrome	9.53e-05	0.000365	CcSEcCtD
Eprosartan—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.47e-05	0.000362	CcSEcCtD
Eprosartan—AGTR1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	9.4e-05	0.0135	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.28e-05	0.0134	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.21e-05	0.0133	CbGpPWpGaD
Eprosartan—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.03e-05	0.000346	CcSEcCtD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCL5—acquired immunodeficiency syndrome	8.94e-05	0.0129	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.39e-05	0.0121	CbGpPWpGaD
Eprosartan—AGTR1—Peptide ligand-binding receptors—CCR5—acquired immunodeficiency syndrome	8.06e-05	0.0116	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	7.89e-05	0.0114	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	7.89e-05	0.0114	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.06e-05	0.0102	CbGpPWpGaD
Eprosartan—AGTR1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	6.84e-05	0.00987	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.39e-05	0.00921	CbGpPWpGaD
Eprosartan—AGTR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.31e-05	0.0091	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.01e-05	0.00866	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.01e-05	0.00866	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6e-05	0.00865	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.87e-05	0.00846	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.72e-05	0.00825	CbGpPWpGaD
Eprosartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.41e-05	0.00779	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.31e-05	0.00765	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.57e-05	0.00659	CbGpPWpGaD
Eprosartan—AGTR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.12e-05	0.00593	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.62e-05	0.00523	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.61e-05	0.0052	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.47e-05	0.005	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.47e-05	0.005	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.39e-05	0.00489	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.39e-05	0.00489	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.28e-05	0.00473	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	3.19e-05	0.0046	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.13e-05	0.00452	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.08e-05	0.00444	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.08e-05	0.00444	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.58e-05	0.00372	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.54e-05	0.00367	CbGpPWpGaD
Eprosartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	2.48e-05	0.00357	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.34e-05	0.00338	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.33e-05	0.00335	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.31e-05	0.00333	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.14e-05	0.00309	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.11e-05	0.00305	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.94e-05	0.00279	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.82e-05	0.00263	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.82e-05	0.00263	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	1.67e-05	0.00241	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	1.42e-05	0.00205	CbGpPWpGaD
Eprosartan—ABCC2—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.42e-05	0.00204	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.39e-05	0.002	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.36e-05	0.00197	CbGpPWpGaD
Eprosartan—AGTR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.34e-05	0.00194	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.25e-05	0.0018	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.22e-05	0.00176	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.21e-06	0.00104	CbGpPWpGaD
Eprosartan—AGTR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.17e-06	0.00103	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	6.55e-06	0.000944	CbGpPWpGaD
Eprosartan—AGTR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.24e-06	0.000611	CbGpPWpGaD
Eprosartan—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	2.92e-06	0.00042	CbGpPWpGaD
